Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AtomVie Global Radiopharma is a leading CDMO specializing in the GMP manufacturing and global distribution of clinical and commercial radiopharmaceuticals. The company leverages over a decade of expertise spun out from the Centre for Probe Development & Commercialization. It supports clients’ programs from early clinical development through pivotal trials to commercialization, with a focus on reliability, logistics excellence, and regulatory compliance. Its new state-of-the-art facility will open in late 2025 to expand capacity further.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AtomVie Global Radiopharma.